Materials, components, assembly, design services, and devices including inhalers, nebulizers, and spray pumps
H&T Presspart specialises in the manufacturer of bespoke, concept-to-completion, metal and plastic drug delivery components and devices for the pharmaceutical market. Presspart has over 40 years’ experience in supplying metal metered dose inhaler (MDI) canisters and valve components, plastic actuators and new drug delivery devices. In fact three quarters of inhalers in the world will contain a component manufactured by Presspart, with millions of patients putting their trust in these components every day.
Bespak offers integrated services to support inhalation and nasal drug delivery; from initial combination device design, to formulation development, through to manufacturing. Our solutions span across the full product lifecycle, to help provide drug delivery devices to patients globally. These include pressurised metered dose inhalers (pMDIs), soft mist inhalers (SMIs) and multi dose and single dose nasal spray devices. Our experts have extensive knowledge throughout the entire lifecycle of drug product development to market, as well as accelerating routes to market. Bespak is your true expert CDMO partner for integrated inhalation and nasal platform offerings.
Iconovo is a world-leading Swedish company that offers a winning combination of innovative inhalation solutions comprising dry powder inhalers (DPI) and formulations to suit the chosen device. Thanks to our extensive experience in designing and optimizing dry powder inhalation products, we help pharmaceutical companies, both generic and originators, to bring their products to the market faster and with less risk. With three different inhaler platforms, which can be adapted to our customers’ unique needs and requirements, we cover the full spectrum of inhaled treatment of respiratory diseases.
Merxin Ltd makes inhalers: multidose dry powder inhalers, capsule dry powder inhalers, soft mist inhalers and devices tailored to deliver cannabinoids to the lungs. Our customers take our devices and combine them with their drug formulation to make final dosage forms that are supplied to users and patients. We create, develop and supply inhalers for evaluation through to commercial supply. Our goal is your commercial launch, what is yours? Merxin creates, develops and supplies inhalers for evaluation through to commercial supply. Get in touch with us to find out about terms of access to our devices: info@merxin.com
Visit the Merxin website
PARI is a world leader in the development of aerosol delivery devices. PARI Pharma focuses on pharma licensing partnerships that utilize eFlow® Technology nebulizers optimized to specific drug products and formulations. eFlow Technology is an aerosol delivery platform that stands for efficient nebulization of liquid medications via a vibrating, perforated membrane – while enabling short development times. eFlow Technology devices are designed to reduce the burden of treatment for patients with severe respiratory conditions. As of today, five commercial drug specific eFlow Technology nebulizers are available in North America, Europe, and Japan.
Visit the PARI Pharma website
Visit the RxPack website
Would you like to list your company in this section or upgrade your existing listing? For information about supplier listing options, click here.